Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3′ overhang specific DNA

FASEB Journal

Volumn 17, Issue 2, 2003, Pages 152-162

  Eller, Mark S ^a   Li, Guang zhi ^a   Firoozabadi, Reza ^a   Puri, Neelu ^a   Gilchrest, Barbara A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ATM; DNA damage responses; p53 phosphorylation; Senescence

Indexed keywords

ATM PROTEIN; GENE PRODUCT; OLIGONUCLEOTIDE; PROTEIN P53; PROTEIN P95; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; GENE ACTIVATION; GENE DISRUPTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NEWBORN; NIJMEGEN BREAKAGE SYNDROME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TELOMERE;

BASE SEQUENCE; CELL CYCLE; CELL CYCLE PROTEINS; CELLS, CULTURED; DNA; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; FIBROBLASTS; HUMANS; INFANT, NEWBORN; JURKAT CELLS; NUCLEAR PROTEINS; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; S PHASE; TELOMERASE; TIME FACTORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0037309426     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-0197com     Document Type: Article

References (76)

1. Campisi, J. (1996) Replicative senescence: an old lives tale? Cell 84, 497-500
2. Greider, C. W. (1996) Telomere length regulation. Annu. Rev. Biochem. 65, 337-365
3. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L., Avilion, A. A., Chiu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, W. H., Greider, C. W., and Villeponteau, B. (1995) The RNA component of human telomerase. Science 269, 1236-1241
4. Harrington, L., McPhail, T., Mar, V., Zhou, W., Oulton, R., Bass, M. B., Arruda, I., and Robinson, M. O. (1997) A mammalian telomerase-associated protein. Science 275, 973-977
5. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., and Cech, T. R. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-957
6. Chan, S. W., and Blackburn E. H. (2002) New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin. Oncogene 21, 553-563
7. de Lange, T. (2002) Protection of mammalian telomeres. Oncogene. 21, 532-540
8. Harrington, L., and Robinson, M. O. (2002) Telomere dysfunction: multiple paths to the same end. Oncogene 21, 592-597
9. Griffith, J. D., Comeau, L., Rosenfeld, S., Stansel, R. M., Bianchi, A., Moss, H., and de Lange, T. (1999) Mammalian telomeres end in a large duplex loop. Cell 97, 503-514
10. van Steensel, B., Smogorewska, A., and de Lange, T. (1998) TRF2 protects telomeres from end-to-end fusions. Cell 92, 401-413
11. Baumann, P., and Cech, T. R. (2001) Pot, the putative telomere end-binding protein in fission yeast and humans. Science 292, 1171-1175
12. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., and de Lange, T. (1999) p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283, 1321-1325
13. n repeats. Nucleic Acids Res. 29, 5207-5215
14. Saretzki, G., Sitte, N., Merkel, U., Wurm, R., and von Zglinicki, T. (1999) Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments. Oncogene 18, 5148-5158
15. Blackburn, E. (2000) Telomere states and cell fates. Nature (London) 408, 53-56
16. Shiloh, Y. (1997) Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu. Rev. Genet. 31, 635-662
17. Lim, D. S., Kim, S. T., Xu, B., Maser, R. S., Lin, J., Petrini, J. H., and Kastan, M. B. (2000) ATM phosphorylates p95/nbs1 in an S phase checkpoint pathway. Nature (London) 404, 613-617
18. Wu, X., Ranganathan, V., Weisman, D. S., Heine, W. F., Ciccone, D. N., O'Neill, T. B., Crick, K. E., Pierce, K. A., Lane, W. S., Rathbun, G., Livingston, D. M., and Weaver, D. T. (2000) ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature (London) 405, 477-482
19. Zhao, S., Weng, Y. C., Yuan, S. S., Lin, Y. T., Hsu, H. C., Lin, S. C., Gerbino, E., Song, M. H., Zdzienicka, M. Z., Gatti, R. A., Shay, J. W., Ziv, Y., Shiloh, Y., and Lee, E. Y. (2000) Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature (London) 405, 473-477
20. Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G., Raams, A., Byrd, P. J., Petrini, J. H., and Taylor, A. M. (1999) The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99, 577-587
21. Paull, T. T., and Gellert, M. (1999) Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre/Rad50 complex. Genes Dev. 13, 1276-1288
22. Trujillo, K. M., Yuan, S. S., Lee, E. Y., and Sung, P. (1998) Nuclease activities in a complex of human recombination and DNA repair factors Rad50, Mre11, and p95. J. Biol. Chem. 273, 21447-21450
23. Nelms, B. E., Maser, R. S., MacKay,J. F., Lagally, M. G., and Petrini,J. H.J. (1998) In situ visualization of DNA double-strand break repair in human fibroblasts. Science 280, 590-592
24. Carney, J. P., Maser, R. S., Olivares, H., Davis, E., Le Beau, M., Yates, III, J. R., Hays, L., Morgan, W. F., and Petrini, J. H. (1998) The hMRE11/hRAD50 protein complex and Nijmegen break-age syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93, 477-486
25. Xu-Dong, Z., Kuster, B., Mann, M., Petrini, J. H. J., and de Lange T. (2000) Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat. Genet. 25, 347-351
26. Chamankhah, M., and Xiao, W. (1999) Formation of yeast Mre11-Rad50-Xrs2 complex is correlated with DNA repair and telomere maintenance. Nucleic Acids Res. 27, 2072-2079
27. Nugent, C. I., Bosco, G., Ross, L. O., Evans, S. K., Salinger, A. P., Moore, J. K., Haber, J. E., and Lundblad, V. (1998) Telomere maintenance is dependent on activities required for end repair of double-strand breaks. Curr. Biol. 8, 657-660
28. Ritchie, K. B., and Petes, T. D. (2000) The Mre11p/Rad50p/Xrs2p complex and the Tep function in a single pathway for telomere maintenance in yeast. Genet 155, 475-479
29. Eller, M. S., Maeda, T., Magnoni, C., Atwal, D., and Gilchrest, B. A. (1997) Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc. Natl. Acad. Sci. USA 94, 12627-12632
30. Goukassian, D. A., Bagheri, S., el-Keeb, L., Eller, M. S., and Gilchrest, B. A. (2002) DNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacity. FASEB J. 16, 754-756
31. Khlgatian, M. K., Hadshiew, I. M., Asawanonda, P., Yaar, M., Eller, M. S., Fujita, M., Norris, D. A., and Gilchrest, B. A. (2002) Tyrosinase gene expression is regulated by p53. J. Invest. Dermatol. 118, 126-132
32. Maeda, T., Eller, M. S., Hedayati, M., Grossman, L., and Gilchrest, B. A. (1999) Enhanced repair of benzo(a)pyrene-induced DNA damage in human cells treated with thymidine dinucleotides. Mutat. Res. 433, 137-145
33. Eller, M. S., Yaar, M., and Gilchrest, B. A. (1994) DNA damage and melanogenesis. Nature (London) 372, 413-414
34. Eller, M. S., Ostrom, K., and Gilchrest, B. A. (1996) DNA damage enhances melanogenesis. Proc. Natl. Acad. Sci. USA 93, 1087-1092
35. Hadshiew, I. M., Eller, M. S., Gasparro, F. P., and Gilchrest, B. A. (2001) Stimulation of melanogenesis by DNA oligonucleotides: effect of size, sequence and 5′ phosphorylation. J. Dermatol. Sci. 25, 127-138
36. Pedeux, R., Al-Irani, N., Mateau, C., Pellicier, F., Branche, R., Ozturk, M., Franchi, J., and Dore J.-F. (1998) Thymidine dinucleotides induce S phase cell cycle arrest in addition to increased melanogenesis in human melanocytes. J. Invest. Dermatol. 111, 472-477
37. Cruz, P. D. Jr, Leverkus, M., Dougherty, I., Gleason, M. J., Eller, M. S., Yaar, M., and Gilchrest, B. A. (2000) Thymidine dinucleotides inhibit contact hypersensitivity and activate the gene for tumor necrosis factor α. J. Invest. Dermatol. 114, 253-258
38. Eller, M. S., Puri, N., Hadshiew, I. N., Venna, S. S., and Gilchrest, B. A. (2002) Induction of apoptosis by telomere 3′ overhang specific DNA. Exp. Cell Res. 276, 185-193
39. Caspari, T. (2000) How to activate p53. Curr. Biol. 10, 315-317
40. Lambert, P. F., Kashanchi, F., Radonovich, M. F., Shiekhattar, R., and Brady, J. N. (1998) Phosphorylation of p53 serine 15 increases interaction with CBP. J. Biol. Chem, 273, 33048-33053
41. Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Taya, Y., Prives, C., and Abraham, R. T. (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13, 152-157
42. Unger, T., Sionov, R. V., Moallem, E., Yee, C. L., Howley, P. M., Oren, M., and Haupt, Y. (1999) Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 18, 3205-3212
43. Vaziri, C., and Faller, D. V. (1995) Repression of platelet-derived growth factor β-receptor expression by mitogenic growth factors and transforming oncogenes in murine 3T3 fibroblasts. Mol. Cell. Biol. 15, 1244-1253
44. van Steensel, B., and de Lange, T. (1997) Control of telomere length by the human telomeric protein TRF-1. Nature (London) 385, 740-743
45. Harley, C. B., Futcher, A. B., and Greider, C. W. (1990) Telomeres shorten during ageing of human fibroblasts. Nature (London) 345, 458-460
46. Wright, W. E., Brasiskyte, D., Piatyszek, M. A., and Shay, J. W. (1996) Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J. 15, 1734-1741
47. Kowalik, T. F., DeGregori, J., Schwarz, J. K., and Nevins, J. R. (1995) E2F1 over-expression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69, 2491-2500
48. Kowalik, T. F., DeGregori, J., Leone, G., Jakoi, L., and Nevins, J. R. (1998) E2F-1-specific induction of apoptosis and p53 accumulation which is blocked by Mdm2. Cell Growth Diff. 9, 113-118
49. Dumaz, N., and Meek, D. W. (1999) Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 18, 7002-7010
50. Banin, S., Moyal, L., Shieh, S., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., and Ziv, Y. (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-1677
51. Canman, C. E., Lim, D. S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Astan, M. B., and Siliciano, J. D. (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679
52. Lin, W. C., Lin, F. T., and Nevins, J. R. (2001) Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15, 1833-1844
53. Wolf, D. A., Hermeking, H., Albert, T., Herzinger, T., Kind, P., and Eick, D. (1995) A complex between E2F and the pRb-related protein p130 is specifically targeted by the simian virus 40 large T antigen during cell transformation. Oncogene. 10, 2067-2078
54. Zalvide, J., and DeCaprio, J. A. (1995) Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15, 5800-5810
55. Rheinwald, J. G., Jermaine, E., and Beckell, M. A. (1983) Human carcinogenesis. In Human Carcinogenesis (Harris, C. C., and Autrup H. N., eds) pp. 86-96, Academic Press, New York
56. Eller, M. S., and Gilchrest, B. A. (2000) Tanning as part of the eukaryotic SOS response. Pigment Cell. Res. 13, 94-97
57. Wang, L. H., Okaichi, K., Ihara, M., and Okumura, Y. (1998) Sensitivity of anticancer drugs in Saos-2 cells transfected with mutant p53 varied with mutation point. Anticancer Res. 18, 321-325
58. Sionov, R. V., and Haupt, Y. (1999) The cellular response to p53: The decision between life and death. Oncogene 18, 6145-6157
59. Akagi, T., Ono, H., Tsuchida, N., and Shimotohno, K. (1997) Aberrant expression and function of p53 in T-cells immortalized by HTLV-I Tax. FEBS 406, 263-266
60. Krek, W., Xu, G., and Livingston, D. M. (1995) Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83, 1149-1158
61. Hande, M. P., Samper, E., Lansdorp, P., and Blasco, M. (1999) Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Bio. 144, 589-601
62. Marusic, L., Anton, M., Tidy, A., Wang, P., Villeponteau, B., and Bacchetti, S. (1997) Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability. Mol. Cell. Biol. 17, 6394-6401
63. Naka, K., Yokozaki, H., Yasui, W., Tahara, H., Tahara, E., and Tahara, E. (1999) Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines. Biochem. Biophys. Res. Comm. 255, 753-758
64. Karlseder, J. D., Smogorzewska, A., and de lange, T. (2002) Senescence induced by altered telomere state, not telomere loss. Science 295, 2446-2449
65. Goukassian, D. A., Eller, M. S., Yaar, M., and Gilchrest, B. A. (1999) Thymidine dinucleotide mimics the effect of solar stimulated irradiation on p53 and p53-regulated proteins. J. Invest. Dermatol. 112, 25-31
66. von Zglinicki, T. (2000) Role of oxidative stress in telomere length regulation and replicative senescence. Ann. N. Y. Acad. Sci. 908, 99-110
67. Greenberg, R. A., Allsopp, R. C., Chin, L., Morin, G. B., and dePinho, R. A. (1998) Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16, 1723-1730
68. Funk, W. D., Wang, C. K., Shelton, D. N., Harley, C. B., Pagon, G. D., and Hoeffler, W. K. (2000) Telomerase expression restores dermal integrity to in vitro-aged fibroblasts in a reconstituted skin model. Exp. Cell Res. 258, 270-278
69. Gonzalez-Suarez, E., Samper, E., Ramirez, A., Flores, J. M., Martin-Caballero, J., Jorcano, J. L., and Blasco, M. A. (2001). Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 20, 2619-2630
70. Rudolph, K. L., Millard, M., Bosenberg, M. W., and DePinho, R. A. (2001) Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28, 155-159
71. Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., Park, S. H., Thompson, T., Karsenty, G., Brady, A., and Donehower, L. A. (2002) p53 mutant mice that display early ageingassociated phenotypes. Nature (London) 415, 45-523
72. Setlow, R. B., and Carrier, W. L. (1966) Pyrimidine dimers in ultraviolet-irradiated DNA's. J. Mol. Biol. 17, 237-254.
73. Kasai, H., and Nishimura, S. (1991) Formation of 8-hydroxydeoxyguanosine in DNA by oxygen radicals and its biological significance. In Oxidative Stress: Oxidants and Antioxidants (Sies, H., ed) pp. 99-116, Academic Press, London
74. Friedberg, E. C., Walker, G. C., and Siede, W. (1995) DNA Repair and Mutagenesis, ASM Press, Washington, DC
75. Gilchrest, B. A., and Eller, M. S. (1999) DNA photodamage stimulates melanogenesis and other photoprotective responses. Invest. Dermatol. Symp. Proc. 4, 35-40
76. Kobayashi, N., Katsumi, S., Imoto, K., Nakagawa, A., Miyagawa, S., Furumur, M., and Mori, T. (2001) Quantitation and visualization of ultraviolet-induced DNA damage using specific antibodies: application to pigment cell biology. Pigment Cell Res 14, 94-102